Clinical Trial

Phenytoin in Treatment of Atrophic Post Acne Scars.

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated April 24, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of topical phenytoin spanlastics as an adjuvant therapy in treatment of atrophic post acne scars. To compare the efficacy of topical phenytoin spanlastics combined with fractional co2 laser versus fractional co2 laser alone in treatment of atrophic post acne scars.
Trial Details
NCT Number NCT06942468
Lead Sponsor Assiut University
Conditions Atrophic Acne Scar
Enrollment 30 participants
Start Date 2025-07-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-24